Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

How to Prevent Heart Failure Readmission by Using Lung Impedance Device (HOPE-HF Study)

NCT04080388 is registered in ClinicalTrials.gov with Hillel Yaffe Medical Center as lead sponsor.

NCT NCT04080388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04080388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
How to Prevent Heart Failure Readmission by Using Lung Impedance Device (HOPE-HF Study)
Lead sponsor
Hillel Yaffe Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2019
Completion date
September 30, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure acute